Dyspareunia
📧 Sign up to get email alerts when something new happens for Dyspareunia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Genital Laser Treatment in Postmenopausal Patients [NA]
Clinical trial update for a genital laser treatment in postmenopausal patients with dyspareunia and vulvar atrophy; the study is currently a…
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Effects of Photobiomodulation on Pain and Sexual Function in Women With Dyspareunia: Randomized Clinical Trial [NA]
A randomized clinical trial evaluating the effects of photobiomodulation on pain and sexual function in women with dyspareunia, currently no…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Effects of Myofascial Release With and Without Thiele Massage [NA]
Clinical trial evaluating myofascial release with and without Thiele massage has completed; the study investigated dyspareunia and pain.
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy [Phase 3]
A Phase 3 clinical trial comparing Estradiol Vaginal Inserts 4 mcg to IMVEXXY for the treatment of dyspareunia in women with vulvar and vagi…
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment [Phase 2]
Phase 2 trial update for a topical botanical drug targeting sexual penetration pain in postmenopausal women; study terminated with posted re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia [Phase 4]
Clinical trial update from a Phase 4 study assessing daily prasterone effects on vulvar and vaginal tissues in women with dyspareunia.
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: A Clinical Investigation Into the Effectiveness and Safety of Five Water Based Personal Lubricants. [Phase 3]
Phase 3 clinical trial evaluating the effectiveness and safety of five water-based personal lubricants; study completed.
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: A Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dysfunction [Phase 4]
Phase 4 trial update on pelvic floor chemodenervation in patients undergoing physical therapy for high tone pelvic floor dysfunction has com…
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Treating Postmenopausal Dyspareunia Where it Hurts [Phase 4]
Phase 4 clinical trial update for treating postmenopausal dyspareunia has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA [Phase 4]
Phase 4 clinical trial evaluating daily ospemifene for vulvar and vaginal changes related to vulovaginal atrophy and dyspareunia; study comp…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy [Phase 3]
Phase 3 trial update evaluating Intrarosa in women with genitourinary syndrome of menopause and vulvovaginal atrophy; the current status of …
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: Rapidly Absorbing Polyglactin 910 Versus Poliglecaprone 25 for Laceration Repair [NA]
A completed clinical trial comparing rapidly absorbing polyglactin 910 versus poliglecaprone 25 for laceration repair, with listed condition…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: The Vaginal Health Trial [Phase 3]
Phase 3 Vaginal Health Trial sponsored by Fred Hutchinson Cancer Center completed with results posted in July 2018, evaluating treatment for…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women [Phase 3]
This Phase 3 clinical trial update reports results for estradiol vaginal softgel capsules in treating symptoms of vulvar and vaginal atrophy…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Outcomes of Delivery in Patients With Dyspareunia
Clinical trial completion study examining delivery outcomes in patients with dyspareunia, with related conditions including provoked vestibu…
-
CLINICAL_TRIALS other · 2016-10-05Clinical Trial Update: Physiotherapy Intervention in Climacteric Women With Dyspareunia [NA]
This clinical trial update notes that a physiotherapy intervention for dyspareunia in climacteric women has completed. The listed sponsor is…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy [Phase 2]
Phase 2 trial TXV13-01 assessed estradiol vaginal softgel capsules for postmenopausal vulvar and vaginal atrophy. The study has completed an…
-
FDA approval · 2015-08-24FDA Approved: OSPHENA — Supplemental Application (Duchesnay USA, Inc.)
FDA approved a supplemental application for OSPHENA (ospemifene) filed by Duchesnay USA, Inc.
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Therapy to Prevent Sexual Pain in Breast Cancer Survivors [Phase 3]
Phase 3 clinical trial evaluating a therapy to prevent sexual pain in breast cancer survivors has completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: Postpartum Dyspareunia Resulting From Vaginal Atrophy
A completed clinical trial update from Meir Medical Center concerns postpartum dyspareunia caused by vulvovaginal atrophy; no specific drug …
-
FDA approval · 2015-02-25FDA Approved: OSPHENA — Supplemental Application (Duchesnay USA, Inc.)
The FDA approved a supplemental application for Osphena (ospemifene) from Duchesnay USA, Inc., confirming/expanding the labeling related to …
-
CLINICAL_TRIALS research · 2014-09-11Clinical Trial Update: Continuous Versus Cyclic Oral Contraceptives for Endometriosis [Phase 4]
A Phase 4 trial comparing continuous versus cyclic oral contraceptives for endometriosis, focusing on symptoms like dysmenorrhea and pelvic …
-
CLINICAL_TRIALS trial_result · 2014-07-22Clinical Trial Update: Acupuncture for the Treatment of Vulvodynia [NA]
This document notes the completion of a clinical trial evaluating acupuncture for vulvodynia and related sexual pain conditions, including v…
-
FDA approval · 2014-05-02FDA Approved: OSPHENA — Supplemental Application (Duchesnay USA, Inc.)
FDA approved a supplemental application for OSPHENA (ospemifene) submitted by Duchesnay USA, Inc.
-
FDA approval · 2014-01-08FDA Approved: OSPHENA — Supplemental Application (Duchesnay USA, Inc.)
FDA approved a supplemental application for Osphena (ospemifene) submitted by Duchesnay USA, Inc.